Introduction
Periodontal disease is defined as any condition affecting the periodontium [1] , which is the consortium of tissues surrounding and supporting the tooth, including the gingiva and alveolar bone. The most common are those caused by the accumulation of a bacterial biofilm on the tooth surface, triggering inflammation and subsequent destruction of the periodontium. The inflammatory processes involve the activation of the broad axis of innate immunity, specifically by up-regulation of proinflammatory cytokines [2] [3] [4] [5] . Pro-inflammatory cytokines including members of the Interleukin (IL)-1 family, such as IL-1β and IL-18, are present in the diseased periodontium and their unbalanced production appears to mediate periodontal tissue destruction [6] [7] [8] [9] .
Porphyromonas gingivalis is a Gram-negative bacterial species, which constitutes a major component of the pathogenic microbiota implicated in chronic periodontitis, [10] [11] [12] [13] . This is a form of periodontal disease characterised by the progressive destruction of the alveolar bone, eventually leading to tooth loss.
Recent evidence demonstrates that the downstream processing of IL-1β is regulated by a cytosolic protein complex of the nucleotide-binding oligomerization domain-like receptor (NLR) protein family, namely NALP3 / CryopyrinInflammasome [14, 15] . This is essentially a family of intracellular innate immune sensors that can respond to bacterial challenge, initiating early host responses [16] .
The inflammasome cooperates with the Toll-like receptor (TLR) pathways to mediate a rapid response to pathogens [17, 18] . NALP3 (also known as PYPAF-1, NLRP3 or Cryopyrin) exerts its inflammatory effects through apoptosis associated speck-like protein (ASC) that functions as an adaptor to downstream pathways [19] . Coexpression of NALP3 and ASC activate Caspase-1, which in turn leads to cleavage and activation of IL-1β [20] . Moreover, NLRP2 (PYPAF-2, or Pyrin), a protein related to the NALP3 inflammasome, was shown to inhibit NALP3-ASC interactions [21] . Recent studies revealed an essential role for NALP3 inflammasome in mediating IL-1β production in response to several bacterial ligands including LPS, peptidoglycan, bacterial and viral RNA [22] [23] [24] [25] [26] . Peripheral blood mononuclear cells (PBMCs), particularly monocytes, which are known to be high producers of IL-1β, are reported to express NALP3 mRNA [27, 28] , and this was highly induced by bacterial lipopolysaccharide (LPS) [29] . Moreover, NALP3-deficient macrophages do not produce IL-1β in response to bacterial stimulation [23, 24, 30, 31] . Interestingly, monocytes from patients with a mutation within the nucleotide-binding oligomerization domain of the NALP3 gene, exhibit spontaneous activation of IL-1β production that can be further potentiated by LPS [32] . Notably, treatment of these patients with an IL-1 receptor antagonist reverses the clinical symptoms, suggesting a cause-effect relationship between IL-1β production and the development of disease [33] .
The fundamental involvement of inflammasome complexes in inflammatory responses is been emphasized by the fact that mutations in the NALP3 gene are strongly associated with auto-inflammatory conditions, such as rheumatoid arthritis, Muckle-Wells syndrome, Crohn's disease, familial cold auto-inflammatory syndrome, but also septic shock [34] [35] [36] [37] [38] [39] . Hyper-production of IL-1β is considered to be a central event in the pathogenesis of auto-inflammatory conditions [40] .
The potential involvement of NALP3 in the pathogenesis of more common inflammatory disorders prompted us to investigate its role in periodontal diseases [26] . While it is known that the NALP3 inflammasome is expressed in monocytic cells, the regulation of this by periodontal pathogens has yet to be revealed. We hypothesized that the inflammasome complex would be altered in patients with periodontal disease, and that its expression would be regulated in monocytic cells challenged by periodontal pathogens. Therefore, the aim of this study was to investigate the gene expression of NALP3, NLRP2, ASC, IL-18 and IL-1β in clinical samples of gingival tissues from patients with various forms of periodontal disease and healthy subjects. The further aim was to investigate in vitro the regulation of this complex by P. gingivalis in a human monocytic cell line, namely Mono-Mac-6.
Materials and Methods

Study population and clinical examination
A total of 58 subjects were included in this study, recruited from the Department of 
Collection of gingival tissue samples
Gingival tissue samples, including both epithelium and connective tissue, were taken from the approximal sites of single rooted teeth prior to non-surgical periodontal therapy in the instance of periodontally diseased subjects, and during tooth extractions for orthodontic reasons, or crown lengthening procedures in healthy subjects. One tissue sample from each subject was obtained and immediately submerged in a sterile tube containing RNAlater solution (Ambion Inc, Austin, TX, USA), stored at -40°C until further laboratory analysis.
RNA isolation and Reverse Transcription
Total RNA from gingival tissue biopsies was extracted using the RiboPure RNA Isolation Kit (Ambion Inc, Austin, TX, USA), according to the manufacturer's instructions. The extracted total RNA concentration was quantified using NanoDrop ® ND-1000 spectrophotometer (NanoDrop Technologies, USA). One µg of total RNA was incubated with 0.5 µg/ml of oligo dT primer (Promega, Southampton, UK) at 
Quantitative real-time PCR (qPCR) analysis
To quantify the mRNA expression levels, qPCR was performed on the prepared cDNA samples. TaqMan® Gene Expression Assays (Applied Biosystems, UK) and ROX qPCR mastermix were used for the amplification reactions, and the qPCR analyses were performed in an ABI Prism 7900HT Sequence Detection System (Applied Biosystems, UK). The expressions of following target genes (Assay ID) were investigated: NALP3 (Hs00918085-m1), ASC (Hs01547324-m1), NLRP2 (Hs01546938-m1), IL-18 (Hs01038787-ml), and IL1β (Hs00174097-m1). The housekeeping genes used to normalise the target gene Ct values in the clinical samples were GAPDH (Hs99999905-m1) and 18S rRNA (Hs99999901-s1), while the ones used for the in vitro experiments were ubiquitin C (UBC) (Hs01871556-m1) and controls, which generated a Ct greater than 40 in all experiments. The expression levels were calculated by using the comparative Ct method (2 −∆Ct formula) after normalization against the selected housekeeping genes.
Bacterial culture
Porphyromonas gingivalis wild-type W50 strain was grown on blood agar plates supplemented with 5% horse blood in an anaerobic environment containing 80%
nitrogen, 10% hydrogen and 10% CO 2 at 37°C, then was sub-cultured into 10 ml of media consisting of brain heart infusion broth supplemented with 5 µg/ml of hemin.
The following day, the 10 ml culture was inoculated into 90 ml of fresh media. At day 6, the liquid cultures were centrifuged at 8500 rpm for 45 min at 4ºC. The resulting culture supernatant was collected, aliquoted and stored at -80°C, to be used for further experimentation. Total bacterial protein concentration in 6-day culture supernatants of P. gingivalis strain W50 was determined using the Bio-Rad Protein Assay (Bio-Rad, Hertfordshire, UK).
Cell culture
The human myelomonocytic cell line Mono-Mac-6 was obtained from the German
Collection of Microorganisms and Cell Cultures (Mascheroder, Braunschweig, Germany). Mono-Mac-6 cells were cultured in RPMI-Glutamax, supplemented with 10% fetal bovine serum, 1% non-essential amino acids, 1% sodium pyruvate (all from Gibco BRL Life Technologies, UK) and 9 µg/ml bovine insulin (Sigma-Aldrich, UK).
The cells were confirmed to be free of mycoplasma infection prior to experimentation (MycoAlert® Mycoplasma Detection Assay, Lonza, Switzerland). Mono-Mac-6 cells
(1 x 10 6 /ml) were used for induction assays in a total volume of 200 µl per well in the absence or presence of P. gingivalis. The doses used were based on results from previous studies [42] . Each experiment was carried out in triplicate cultures. 
Statistical analysis
RESULTS
NALP3, ASC, NLRP2, IL-1β and IL-18 mRNA expression analysis in gingival tissues by qPCR
The expressions of NALP3, its effector protein ASC, and its putative antagonist NLRP2 were examined in gingival tissues from patients with gingivitis, CP, G-AgP, as well as healthy subjects. All three gene products were readily measurable by qPCR in all tissues. In comparison to healthy tissues, NALP3 expression was significantly (P<0.05) higher in either of the periodontitis groups or gingivitis groups (Fig. 1a) . In particular, NALP3 expression was higher by 7.4-fold in G-AgP, 4.3-fold in CP, and 7.7-fold in gingivitis, respectively. Interestingly, when the three disease groups were compared to each other, no significant differences were observed in the expression of these genes. Likewise, NLRP2 expression was increased in all disease groups compared to healthy tissues (Fig. 1a) , but this was statistically significant (P<0.05) only in G-AgP (6-fold) and gingivitis (8.2-fold). In contrast, there were no significant differences in ASC expression between any of the disease groups and health (Fig. 1c) . 
Regulation of NALP3, ASC, NLRP2, IL-1β and IL-18 mRNA expression by P. gingivalis in monocytic cells
The regulation of the inflammasome complex by P. gingivalis was also studied in vitro. Mono-Mac-6 cells were challenged with ascending protein concentrations of P.
gingivalis W50 strain culture supernatants, for 6 h. The untreated (control) cell cultures expressed low but detectable levels of NALP3 mRNA. Nevertheless, P.
gingivalis challenge elicited a dose-dependent increase in NALP3 mRNA expression, which was up to 3-fold greater to the control (Fig 3a) . In contrast, NLRP2 mRNA expression was highly expressed in the untreated cells, and this was down-regulated in a dose-dependent manner by P. gingivalis challenge (Fig. 3b) . Compared to the control, there was 9.3-fold reduction in NLRP2 expression levels with the highest P.
gingivalis protein concentration used (6.4 µg/ml). Furthermore, ASC was highly expressed in the untreated control, but this was down-regulated up to 15.3-fold with increasing P. gingivalis concentrations (Fig. 3c) . During this period, the expressions of IL-1β (Fig. 3d ) and IL-18 ( Fig. 3e) were enhanced in response to P. gingivalis challenge.
Discussion
The NALP3 Inflammasome complex is predicted to be an essential part of the innate immunity system [43] . The present study is the first to investigate the involvement of this complex in periodontal diseases, demonstrating significantly increased levels of NALP3 and NLRP2, but not ASC, mRNA expression in gingival tissues affected by periodontal disease, compared to health ones. Nevertheless, the impact of age differences between groups as a confounder should not be excluded, especially since this factor may alter immune responses, including the expression of this system. As expected, both IL-1β and IL-18 mRNA expression were also enhanced in periodontal disease compared to health, in consistency with previous findings [8, 9, 44] .
Therefore, we further considered a potential relationship between these two cytokines of the IL-1 family and NALP3, and hypothesized a putative correlation at the tissue gene expression level. Indeed, a positive correlation was revealed, denoting functional relationship of NALP3 with its downstream processing targets IL-1β and IL-18, in periodontal diseases. It is of interest that, while IL-1 cytokines and NALP3
Inflammasome gene expression were significantly higher in gingivitis, CP and G-AgP compared to health, there were no differences among these three disease groups. This indicates that the enhancement of the inflammasome complex expression is distinguishable in the presence of inflammatory periodontal disease. However, it cannot differentiate between periodontitis and gingivitis, and therefore it may not account for the alveolar bone destruction, which occurs in the case of periodontitis, but not gingivitis. We have previously demonstrated that the receptor activator of NF-κB Ligand (RANKL)-osteoprotegerin (OPG) system may be a more suitable indicator of bone destruction, rather than an inflammatory determinant of periodontal disease [45, 46] . Inflammasome complex, sensing and responding to bacterial challenge [29, 48] . We employed the Mono-Mac-6 cell line and selected P. gingivalis, a major periodontal pathogen, as bacterial challenge to investigate the regulation of the NALP3
Inflammasome complex. NALP3 expression was low in untreated cells, but this was significantly elevated upon P. gingivalis challenge, along with the expressions of IL-1β and IL-18. In agreement with these findings, we have previously shown that P.
gingivalis triggers the release of IL-1β and IL-18, the endpoint targets of inflammasome activation, in Mono-Mac-6 cells [42] . Whether NALP3 is directly involved in the induction these cytokines in the present experimental system, needs to be addressed by interventional studies.
The present study also shows that Mono-Mac-6 cells constitutively express ASC, an important adapter molecule in NALP3-mediated cellular responses [29, 49, 50] . Interestingly, P. gingivalis challenge dramatically down-regulated ASC mRNA expression, providing evidence of the functionality of this molecule in the regulation of the NALP3 in human monocytes [51] . These findings are in agreement with a recent report showing a decrease of ASC mRNA expression in differentiated THP-1, after 6 h of challenge with live P. gingivalis [52] . In contrast, another study has demonstrated that E. coli LPS enhances ASC mRNA expression in monocytic cells [53] . This discrepancy could reflect differences in the cell lines used, or the simply the different nature of bacterial stimulation. In fact, P. gingivalis has the capacity to evade immune responses, and thus contribute to the establishment of chronic inflammation [54] . Down-regulation of ASC may be a host response potentially manipulated by P.
gingivalis, in favour of its survival in the infected periodontal tissues, as also discussed by other researchers [52] .
Mono-Mac-6 cells constitutively expressed NLRP2 mRNA, and its levels were reduced after P. gingivalis challenge. NLRP2 was shown to compete with Caspase-1 for binding to ASC [21] , and has also been proposed as an antagonist of NALP3-ASC interactions [55] , thereby exerting a modulatory effect on IL-1β production. Thus, NLRP2 might interfere with NALP3-mediated cytokine production at several points in the signalling cascade [56] . The present demonstration of NLRP2 down-regulation by P. gingivalis may denote that this molecule is part of a negative regulatory loop of the NALP3 Inflammasome complex. 
